Clinical Trial

Tonic Motor Activation (TOMAC) Therapy in Patients With Restless Legs Syndrome and Dopaminergic Augmentation

Name: Tonic Motor Activation (TOMAC) Therapy in Patients With Restless Legs Syndrome and Dopaminergic Augmentation — clinical trial record (NCT07397247)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CT-10

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study evaluates Tonic Motor Activation (TOMAC) therapy in adults with restless legs syndrome and dopaminergic augmentation. Participants use a noninvasive peroneal nerve stimulation device over a defined treatment period to assess symptom response and medication use.

Trial Details

NCT Number	NCT07397247
Lead Sponsor	Noctrix Health, Inc.
Conditions	Restless Legs Syndrome
Enrollment	50 participants
Start Date	2026-04
Primary Completion	2027-01 (estimated)
Study Completion	2027-01 (estimated)
Updated on ClinicalTrials.gov	2026-02-09